viernes, 22 de junio de 2012

CDC U.S. Medical Eligibility Criteria (USMEC) Update

Image showing Division of Reproductive Health Header
USMEC logo



Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised Recommendations for the Use of Hormonal Contraception among Women at High Risk for HIV or Infected with HIV 


Prevention of unintended pregnancy among HIV-infected women or those at risk for HIV is critically important. As an update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, CDC is issuing updated recommendations for the use of hormonal contraceptives among women at high risk for HIV or infected with HIV, based on new scientific evidence. These updated recommendations affirm the previous guidance which states that the use of hormonal contraceptives, including combined hormonal contraceptives, progestin-only pills, depot medroxyprogesterone acetate (DMPA), and implants, is safe for women at high risk for HIV or infected with HIV (US MEC 1), and that all women who use contraceptive methods other than condoms should be counseled about the use of condoms and the risk for sexually transmitted diseases (STIs). However, a clarification is added to the recommendation for women at high risk for HIV who use progestin-only injectables to acknowledge the inconclusive nature of the body of evidence on the association between progestin-only injectable use and HIV acquisition. The clarification also notes the importance of condom use and other HIV preventive measures, expansion of the contraceptive mix, and the need for further research on these issues.


For more information:
  
Continuing education credit is available for this report. For more information:

No hay comentarios:

Publicar un comentario